journal article·2024-07-12

Ultrasonic Diagnosis and Treatment of Tumors Using Multifunctional Hollow Mesoporous Silicon Nanoparticles

Jiawei Zhang, Tiantian Guo, Kunlun Liu, Ke Bao, Xinyi Liu, Sifan Cui, Dixuan Chen, Mulin Jun Li, Siqi Bao, Chunhong Hu, Xi Wei, Xiujun Gao

ACS Applied Nano Materials· Volume 7· Issue 13
Publisher page

Abstract

In recent years, the application of hollow mesoporous silicon nanoparticles in the biomedical field has attracted much attention because of their excellent features. In this study, the sonosensitizer curcumin (Cur), the chemotherapy drug doxorubicin (Dox), and the perfluoropropane (C 3 F 8 ) gas were loaded into a multifunctional hollow mesoporous silica nanoparticle (MHMSN). The surface of MHMSN was modified with a biotin molecule and acid-sensitive groups (cis-aconitic anhydride-polyethylene glycol, CDM-PEG). The as-prepared multifunctional nanoparticle (CDF-MHMSN) demonstrates improved therapeutic efficacy and enhanced tumor contrast ultrasound performance. Surface-modified CDM-PEG can improve the blood circulation ability of nanoparticles and peel off in the acidic tumor microenvironment, which can enhance the endocytosis of cancer cells. As a sonosensitizer, Cur could generate reactive oxygen species (ROS) under ultrasound stimulation to kill tumor cells and reduce the multidrug resistance of tumor cells to the Dox by inhibiting the expression of P-glycoprotein. Overall, CDF-MHMSN exhibits good biocompatibility, excellent ultrasound imaging capability, and effective antitumor ability, which may contribute to improving the treatment strategy for hepatocellular carcinoma.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery · Graphene and Nanomaterials Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Biomedical Engineering and Technology, Tianjin Medical University, 22 Qixiangtai Road, Tianjin 300070, China

Department of Diagnostic and Therapeutic Ultrasonography, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University, Tianjin 300060, China

Funding

National Natural Science Foundation of China · Tianjin Medical University

References (43)

Show source-provided references
1. 10.1038/s41572-020-00240-310.1038/s41572-020-00240-3 ↗
2. 10.1016/j.biopha.2019.10885210.1016/j.biopha.2019.108852 ↗
3. 10.1038/s41392-021-00572-w10.1038/s41392-021-00572-w ↗
4. 10.7150/thno.5782810.7150/thno.57828 ↗
5. 10.1002/smll.20210307210.1002/smll.202103072 ↗
6. 10.1016/j.addr.2022.11448210.1016/j.addr.2022.114482 ↗
7. 10.1002/adfm.20200986010.1002/adfm.202009860 ↗
8. 10.1002/adfm.20221501410.1002/adfm.202215014 ↗
9. 10.1002/adma.20160410510.1002/adma.201604105 ↗
10. 10.1021/acsanm.0c0041010.1021/acsanm.0c00410 ↗
11. 10.1126/sciadv.adi998010.1126/sciadv.adi9980 ↗
12. 10.1021/jacs.2c0960810.1021/jacs.2c09608 ↗
13. 10.1002/adma.20230064810.1002/adma.202300648 ↗
14. 10.1002/adma.20210705410.1002/adma.202107054 ↗
15. 10.1039/C9CS00648F10.1039/C9CS00648F ↗
16. 10.1021/acsanm.3c0595910.1021/acsanm.3c05959 ↗
17. 10.1021/acsanm.3c0454310.1021/acsanm.3c04543 ↗
18. 10.1021/acsanm.2c0353910.1021/acsanm.2c03539 ↗
19. 10.1016/j.addr.2022.11432010.1016/j.addr.2022.114320 ↗
20. 10.1016/j.jconrel.2022.11.02110.1016/j.jconrel.2022.11.021 ↗
21. 10.1039/C9CS00648F10.1039/C9CS00648F ↗
22. 10.1016/j.canlet.2019.11.03410.1016/j.canlet.2019.11.034 ↗
23. 10.1016/j.ijbiomac.2023.12687010.1016/j.ijbiomac.2023.126870 ↗
24. 10.1093/nar/gkaa21610.1093/nar/gkaa216 ↗
25. 10.1016/j.jconrel.2020.08.03310.1016/j.jconrel.2020.08.033 ↗
26. 10.1016/j.mam.2023.10120510.1016/j.mam.2023.101205 ↗
27. 10.1016/j.lfs.2022.12046310.1016/j.lfs.2022.120463 ↗
28. 10.3390/pharmaceutics1211108410.3390/pharmaceutics12111084 ↗
29. 10.1016/j.semcancer.2020.06.01410.1016/j.semcancer.2020.06.014 ↗
30. 10.1016/j.cej.2020.12632310.1016/j.cej.2020.126323 ↗
31. 10.1021/acsami.1c2192410.1021/acsami.1c21924 ↗
32. 10.1002/adfm.20190263410.1002/adfm.201902634 ↗
33. 10.1038/s41578-019-0144-x10.1038/s41578-019-0144-x ↗
34. 10.1002/wnan.151510.1002/wnan.1515 ↗
35. 10.1021/acssensors.2c0146810.1021/acssensors.2c01468 ↗
36. 10.1038/nnano.2012.4510.1038/nnano.2012.45 ↗
37. 10.1016/j.apsb.2021.03.03310.1016/j.apsb.2021.03.033 ↗
38. 10.1039/D3NR03226D10.1039/D3NR03226D ↗
39. 10.1016/j.biomaterials.2012.06.05910.1016/j.biomaterials.2012.06.059 ↗
40. 10.1038/natrevmats.2016.1410.1038/natrevmats.2016.14 ↗
41. 10.3390/cells1204065910.3390/cells12040659 ↗
42. 10.1016/j.biomaterials.2020.12054710.1016/j.biomaterials.2020.120547 ↗
43. 10.1016/j.redox.2022.10234010.1016/j.redox.2022.102340 ↗